Mixson L Sarah, Zule William, Ruderman Stephanie A, Feinberg Judith, Stopka Thomas J, Sibley Adams L, Walters Suzan M, Bobashev Georgiy, Cook Ryan, Hochstatter Karli R, Fahey Carolyn A, Ouellet Lawrence J, Fredericksen Rob, Cooper Hannah L F, Young April M, Zibbell Jon, Khoury Dalia, Friedmann Peter D, Miller William C, Korthuis P Todd, Westergaard Ryan P, Whitney Bridget M, Tsui Judith I, Crane Heidi M, Delaney Joseph
Department of Medicine, University of Washington School of Medicine, 1959 NE Pacific Street, Seattle, WA 98195-6420, United States.
RTI International, 3040 E. Cornwallis Road, PO Box 12194, Research Triangle Park, NC 2709-2194, United States.
Int J Drug Policy. 2025 May 30;143:104837. doi: 10.1016/j.drugpo.2025.104837.
Multiple injections per injection episode (MIPIE) is increasingly common among people who inject drugs (PWID). While MIPIE may lower overdose risk, it could elevate infectious disease risk. This study examined the prevalence of MIPIE among rural PWID in the United States and its associations with injection behaviors associated with disease transmission (e.g., syringe mediated drug sharing, receptive supply sharing) and health outcomes (e.g., hepatitis C virus (HCV) status, naloxone possession, and overdose).
The Rural Opioid Initiative includes eight research cohorts of rural people who use drugs from across the U.S., recruited from 01/2018 to 03/2020. MIPIE was dichotomized as any vs. none using the question: "How many times in the past 30 days did you inject more than one time in one sitting?" We employed a fixed effects meta-analytic approach to examine cross-sectional associations through adjusted regression analyses.
Among 2441 PWID, most reported MIPIE (71% [n=1729]). In adjusted analyses, MIPIE was associated with a higher prevalence of past 30-day receptive syringe sharing (Prevalence Ratio (PR)=2.02; 95% confidence interval (CI)=1.74-2.34), syringe-mediated drug sharing (PR=1.92; 95%CI=1.69-2.18), receptive supply sharing (PR=1.99; 95%CI=1.75-2.26), distributive supply sharing (PR=2.30; 95%CI=1.99-2.65), HCV (PR=1.26; 95%CI=1.11-1.44), naloxone possession (PR=1.32; 95%CI=1.17-1.50), overdose ever (PR=1.42; 95%CI=1.25-1.57), and overdose in the prior 90 days (PR=2.09; 95%CI=1.52-2.87).
MIPIE is a common practice among rural PWID and is associated with injection behaviors associated with disease transmission, HCV, and overdose. Intervention studies should develop harm reduction strategies that address both overdose prevention and infectious disease mitigation related to MIPIE.
在注射吸毒者中,单次注射期间多次注射(MIPIE)现象日益普遍。虽然MIPIE可能会降低过量用药风险,但它可能会增加传染病风险。本研究调查了美国农村注射吸毒者中MIPIE的流行情况及其与疾病传播相关注射行为(如注射器介导的药物共享、接受性供应共享)和健康结果(如丙型肝炎病毒(HCV)感染状况、持有纳洛酮和过量用药)之间的关联。
农村阿片类药物倡议包括来自美国各地的八个农村吸毒者研究队列,于2018年1月至2020年3月招募。使用以下问题将MIPIE分为有或无:“在过去30天里,你有多少次在一次注射中注射超过一次?”我们采用固定效应荟萃分析方法,通过调整后的回归分析来研究横断面关联。
在2441名注射吸毒者中,大多数报告有MIPIE(71%[n = 1729])。在调整分析中,MIPIE与过去30天接受性注射器共享的较高流行率相关(患病率比值(PR)= 2.02;95%置信区间(CI)= 1.74 - 2.34)、注射器介导的药物共享(PR = 1.92;95%CI = 1.69 - 2.18)、接受性供应共享(PR = 1.99;95%CI = 1.75 - 2.26)、分配性供应共享(PR = 2.30;95%CI = 1.99 - 2.65)、HCV感染(PR = 1.26;95%CI = 1.11 - 1.44)、持有纳洛酮(PR = 1.32;95%CI = 1.17 - 1.50)、曾有过量用药经历(PR = 1.42;95%CI = 1.25 - 1.57)以及前90天内的过量用药(PR = 2.09;95%CI = 1.52 - 2.87)相关。
MIPIE在农村注射吸毒者中是一种常见行为,并且与疾病传播、HCV感染和过量用药相关的注射行为有关。干预研究应制定减少伤害策略,以解决与MIPIE相关的过量用药预防和传染病缓解问题。